Transfer factor – development and research of new pharmaceutical forms (Q11224): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
| Property / financed by | |||
| Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 15:42, 28 October 2020
Project Q11224 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transfer factor – development and research of new pharmaceutical forms |
Project Q11224 in Czech Republic |
Statements
24,083,996.56 Czech koruna
0 references
43,285,400.0 Czech koruna
0 references
55.64 percent
0 references
16 April 2018
0 references
30 April 2020
0 references
AUMED, a.s.
0 references
49°59'56.22"N, 14°25'3.50"E
0 references
14300
0 references
Předložený projekt řeší problematiku přípravy nové lékové formy specifických imunomodulátorů na bázi transfer faktorů (TF) a metod testování jejich imunobiologického potenciálu a. (Czech)
0 references
The submitted project addresses the issue of preparation of a new pharmaceutical form of specific immunomodulators based on the transfer of factors (TF) and methods of testing their immunobiological potential a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_083/0010301
0 references